Influence of Casting Solvent and Polymer on Permeability of Propranolol Hydrochloride Through Eudragit RL100 and Eudragit RLPO Films

 

B. Soujanya1*, J. Geethanjali2, D. Mounika3, V. Saikishore4

1Research Scholar, Bapatla College of Pharmacy, Bapatla.

2Department of Analysis,  Bapatla College of Pharmacy, Bapatla.

3Department of Pharmaceutics, Bapatla College of Pharmacy, Bapatla.

4Associate Professor, Department of Pharmaceutics, Bapatla College of Pharmacy, Bapatla-522101, Guntur, Andhra Pradesh, India

*Corresponding Author E-mail: sowji2818@gmail.com

 

ABSTRACT:

In the present work, eudragitL100and Eudragit RLPO films were prepared and evaluated as rate controlling membrane for transdermal drug delivery systems. Dibutyl phthalate or propylene glycol at a concentration of 15w/w of the polymer was used as a plasticizer in the preparation of eudragitL100and Eudragit RLPO films. Casting on mercury surface technique was employed for preparation of eudragitL100and Eudragit RLPO films. The dry films were evaluated for physical appearance, water vapour transmission, drug diffusion and permeability coefficient. Both water vapour transmissions, drug diffusion rate followed zero-order kinetics. The mechanism of drug release was governed by peppas model. The diffusion exponent of release profiles (slope) has a value of1.056-1.071 (n>1), which indicates super case ц transport diffusion. The results obtained in the present study thus indicate that the polymer and solvents used in the preparation of films have shown significant influence on the water vapour transmission, drug diffusion and permeability of the films.

 

KEYWORDS: Polymer, solvents, water vapour transmission, drug diffusion and permeability coefficient.

 

 


INTRODUCTION:

The development of transdermal drug delivery systems using polymeric materials has become popular for various reasons. Among various types of transdermal drug delivery systems developed, membrane controlled type utilizes a thin polymeric film as a rate controlling membrane, which delivers the drug from the reservoir to the systemic circulation for an extended period of time. The permeability of drug through polymeric film dependent on characteristics of the polymer1- 2casting solvent3- 4 and plasticizer5-6 was used. In the present work, eudragitL100 and Eudragit RLPO films were prepared and evaluated as rate controlling membranes for transdermal drug delivery systems. Propranolol hydrochloride7, which requires controlled release due to its short biological half life (3.9h), was used as a model drug.

 

MATERIALS AND METHODS:

Materials Used:

Propranolol  hydrochloride was obtained as a gift sample from Natco Pharma; Hyderabad. Eudragit RLPO Natco Pharma; Hyderabad. Eudragit RL100 (Himedia; Mumbai). Acetone (Qualigens; Mumbai). Ethyl Acetate, Dichloromethane, Chloroform (S. D. fine-chem. Ltd.; Mumbai) Dibutyl Phthalate (Ranbaxy Laboratories; New Delhi) was obtained commercially. All materials were used as received.

 

Preparation of drug free films:

Casting on mercury surface technique was employed in the present work for the preparation of Eudragit RL100and Eudragit RLPO films. In each case films were prepared using solutions of the polymer in various solvents. Acetone, chloroform, dichloromethane and ethyl acetate were used as solvents in the preparation of films. Dibutyl phthalate was included as a plasticizer in the preparation films at a concentration of 15% w/w of the polymer (or 8% w/v of the polymer solution). 8 ml of the polymer solution was poured in a glass bangle (6.4 cm diameter) placed on a mercury  surface. The rate of evaporation was controlled by inverting a funnel over the Petri plate. After 24 hours the dried films were taken out and stored in a desiccator.

Evaluation of transdermal films:

All the films prepared were evaluated for Physical Appearance, Thickness uniformity, Folding Endurance, Water vapour Transmission and Drug Diffusion Study and Permeability Coefficient. The thickness of the films was measured by a ‘dial caliper’. The mean of the five observations were calculated. The folding endurance was measured manually for the prepared films. A strip of film (2x2 cm) was cut evenly and repeatedly folded at the same place till it broke. The number of times the film could be folded at the same place without breaking gave the exact value of folding endurance8. For the study of water vapour transmission (WVT) rate, vials of equal diameter were used as transmission cells. These cells were washed thoroughly and dried in an oven. About 1.0 g of Calcium chloride was taken in the cell and the polymeric films measuring 3.14 Cm2 area were fixed over the brim with the help of an adhesive. The cells were weighed accurately and initial weight is recorded, and then kept in a closed desiccator containing saturated solution of KCl (about 200 ml.). The humidity inside the desiccator was measured by a hygrometer, and it was found to be in between 80 – 90 % RH. The cells were taken out and weighed after 18, 36, 54 and 72h. From increase in weights the amount of water vapour transmitted and the rate at which water vapour transmitted were calculated by using the following formula9.

Where, W= Water vapour transmitted in gms.

L= Thickness of the film in cm.

S= Exposed surface area in cm2.

 

Drug diffusion study10:

Drug diffusion study was conducted using Franz diffusion cell.  The receptor compartment was filled with 15 ml of phosphate buffer having pH 7.4 as diffusion media. Polymeric film was mounted on the donor compartment with the help of an adhesive. 10 ml of the 0.25% W/V of drug solution was poured into the donor compartment. Magnetic stirrer was set at 100 rpm and whole assembly was maintained at 37 + 2 0C. The amount of drug released was determined by withdrawing 1 ml of sample at regular time intervals for 3 hours. The volume withdrawn was replaced with equal volume of fresh buffer solution. Samples were analyzed for drug content using a U V spectrophotometer at 290 nm11.

 

Permeability Coefficient:

From the drug diffusion data the Permeability Co efficient for various films was calculated using the equation

 

                            

 

Where,    Kapp = Diffusion rate constant (mg/h) calculated from the slope of the linear drug (d/p) diffusion profiles. H = Thickness of the film (cm), A = Surface area of the film (cm2).

The rate and mechanism of release of prapranolol hydrochloride through the prepared films were analyzed by fitting the diffusion datainto12,zero-order equation, Q=Q0-k0t,  Where Q is the amount of drug release at time t, and k0is the release rate. First order equation, is LnQ=LnQ0-k1t Where k1is the release rate constant and  Higuchi. Equation, Q=k2t1/2,  Where Q is the amount of drug release at time t, and k2 is the diffusion rate constant.  The  diffusion data was further analyzed to define the mechanism of drug release by applying the diffusion data following the empirical  equation,M1/Mœ=ktn, where Mt/Mœ is the fraction of the drug released at time t, K is a constant and n characterizes of the  mechanism of drug release from the formulations during diffusion process.

 

Statistical Evaluation:

The relevance of difference in the   in-vitro diffusion rate profile was evaluated statistically.  The data were tested by one way analysis of variance (P<0.05) (ANOVA).

 

Skin Irritation Test:

A primary skin irritation test was performed on six healthy rabbits, weighing between 2 to 3.5 kg. The patch of area 3.14cm2 was used as a test patch. The dorsal surface of rabbits was cleared well and the hair was removed by using a depilatory preparation. The skin was cleared with rectified spirit. The transdermal film was placed on the dorsal surface of the abdominal skin with the help of an adhesive tape. The patches were removed after 24 hr and the skin was examined for erythema and edema.

 

RESULTS AND DISCUSSION:

In the present work, Eudragit RL100 and Eudragit RLPO films showed good film forming properties. The method of casting on mercuric surface was found to be giving thin uniform films. The films prepared with polymer alone were found to be brittle. To prevent embrittlement a plasticizer, dibutyl phthalate was tried at various concentrations ranging from 5-15% w/w of the polymer. Preliminary experiments indicated that lower concentrations of dibutyl phthalate were found to give rigid and brittle films where as higher concentrations gave soft films. Dibutyl phthalate at a concentration of 15% w/w of the polymer was found to give good flexible films dibutyl phthalate was included as a plasticizer in the preparation of eudragitL100, Eudragit RLPO films at a concentration of 15%w/w of the polymer All the films prepared were evaluated for uniformity of thickness, folding endurance, water vapour transmission and drug diffusion and permeability characteristics. Thickness measurements of films prepared in various solvents are given in table 1. Low standard deviation values in the film thickness measurements ensured uniformity of thickness in each film. The method of casting on mercuric surface was found to be given reproducible results with regard to film thickness. The folding endurance was measured manually and folding endurance was found to be high in Eudragit RLPO films compared with Eudragit RL100 films. Folding endurance is decreased in the order of films in various solvents is as follows.  Water vapour transmission studies indicated that all the films prepared (both Eudragit RL100 and Eudragit RLPO) were permeable to water vapour. Water vapour transmission through the films followed zero order kinetics. The results are given in table 2.And shown in fig1 and 2.

 

The water vapour transmission (Q) was more in the case of cellulose acetate films when compared to ethyl cellulose. Water vapour transmission values indicating that the cellulose acetate films were more permeable to water vapour. The rate of water vapour transmission was decreased in the order of films in various solvents is as follows.

 

Ethyl acetate > acetone> dichloromethane> chloroform.

 

Drug diffusion through various films was studied with propranolol hydrochloride as a model drug by using Franz diffusion cell. All the films were found to be permeable to Propranolol hydrochloride and the results are given in table 2and shown in fig 3 and 4. The correlation coefficient values (r) were reported in Table 3. These values revealed that the dissolution profiles follow zero order kinetics and the mechanism of drug release was governed by peppas model. The diffusion exponent of release profiles (slope) has a value of 1.056-1.071 (n>1), which indicates super case II transport diffusion13.  Permeability coefficient values (Pm) of the films towards the propranolol hydrochloride was calculated from the drug diffusion data and the results were given in table 3. The rate of permeability coefficient was decreased in the order of films in various solvents is as follows.

 

Ethyl acetate > acetone> dichloromethane> chloroform.

 

The relevance of difference in the   in-vitro diffusion rate profile was evaluated statistically.   Statistical analysis   by using One-way analysis of variance (P<0.05) proves that films prepared with various polymers and casting solvents have significant difference in diffusion of Proponolol Hydrochloride. Skin Irritation studies were conducted according to the procedure described earlier. The examination of applied area indicated neither erythema nor edema. Hence it was concluded that the transdermal gels were free from skin irritation. The results obtained in the present study thus indicated that the solvent used has significant influence on the water vapour transmission, drug diffusion and permeability of the films. Shown high Permeability coefficient values (Pm) of the Eudragit RLPO films towards the propranolol hydrochloride was high when compared to the Permeability coefficient values of Eudragit RL100 films. Among all the films, Eudragit RLPO films prepared with Ethylacetate shown high Permeability when compared to other films. Among all the films, Eudragit RLPO films prepared with Ethylacetate Permeability when compared to other films.


 

 

Table 1: Mechanical properties of transdermal films:

Polymer

Formulation

Casting solvent

Thickness

Folding endurance

EUDRAGIT

RL100

F1

Acetone

37.8

111

F2

Dichloromethane

40.2

107

F3

Chloroform

37.0

105

F4

Ethyl Acetate

39.6

136

EUDRAGIT

RLPO 100

F5

Acetone

28.0

120

F6

Dichloromethane

41.4

110

F7

Chloroform

42.8

116

F8

Ethyl Acetate

37.6

145

 

 

 

Table 2: Mechanical properties of transdermal films:

Polymer

Formulation

Casting solvent

Water vapour transmission,

(qgm/cm2.24h)

Permeability coefficient

(pm x 10  mg/cm.hs )

Eudragit

Rl100

F1

Acetone

3.1419

8.218

F2

Dichloromethane

3.14942

8.685

F3

Chloroform

2.2624

7.957

F4

Ethyl Acetate

3.960

8.613

Eudragit

RLPO100

F5

Acetone

2.478

6.061

F6

Dichloromethane

3.0454

8.996

F7

Chloroform

2.7806

9.205

F8

Ethyl Acetate

3.915

8.201

 


 

Fig.1: Water Vapour Transmission Profiles of Eudragit RL100 Films Casted With Various Solvents

(-♦-) F1 (Eudragit RL100 films prepared with acetone)

 (-■-) F2 (Eudragit RL100 films prepared with dichloromethane)

(-▲-) F3 (Eudragit RL100 films prepared with chloroform)

 (-×-) F4 (Eudragit RL100 films prepared with ethyl acetate)

 

Fig 2 Water Vapour Transmission Profiles of Eudragit RLPO Films Casted With Various Solvents

(♦-) F5 (Eudragit RLPO films prepared with acetone)

(-■-) F6 (Eudragit RLPO films prepared with dichloromethane)

(-▲-) F7 (Eudragit RLPO films prepared with chloroform)

(-×-) F8 (Eudragit RLPO films prepared with ethyl acetate)

 

 

Fig 3: Diffusion Profiles of Propranolol Hydrochloride through Eudragit RL100 Films Prepared With Various Solvents

(-♦-) F1 (Eudragit RL100 films prepared with acetone)

(-■-) F2 (Eudragit RL100 films prepared with dichloromethane)

(-▲-) F3 (Eudragit RL100 films prepared with chloroform)

(-×-) F4 (Eudragit RS 100 films prepared with ethyl acetate)

 

 

Fig 4: Diffusion Profiles of Propranolol Hydrochloride through Eudragit RLPO Films Prepared With Various Solvents

(♦-) F5 (Eudragit RLPO films prepared with acetone)

(-■-) F6 (Eudragit RLPO films prepared with dichloromethane)

(-▲-) F7 (Eudragit RLPO films prepared with chloroform)

(-×-) F8 (Eudragit RLPO films prepared with ethyl acetate)

 


 

 

TABLE 3: Diffusion characteristics of Propranolol hydrochloride through eudragitL100and eudragit RLPO with various solvents:

Formulation

Correlation Coefficient (r) values

Zero order rate constant (k) value (mg/h)

Diffusion

Exponent value (n)

Zero order

First   order

Higuchi model

Peppas Model

F1

0.9989

0.9909

0.9222

0.9998

2.97

1.067

F2

0.9989

0.9924

0.9212

0.9993

2.44

1.060

F3

0.9984

0.9940

0.9219

0.9995

2.03

1.056

F4

0.9987

0.9881

0.9215

0.9997

3.50

1.068

F5

0.9988

0.9883

0.9213

0.9928

3.36

1.065

F6

0.9989

0.9916

0.9221

0.9998

2.82

1.067

F7

0.9981

0.9942

0.9243

0.9999

2.28

1.056

F8

0.9990

0.9857

0.9222

0.9989

4.05

1.071


ACKNOWLEDGEMENTS:

The author expresses sincere thanks to gift sample from Natco Pharma, Hyderabad Yarrow Chem. for providing us gift sample and to Bapatla Society for providing necessary facilities.

 

REFERENCES:

1.       S.J. Lee and S.W. Kim, Temperature and pH-Response Swelling Behavior of poly(2-ethyl-2-oxazoline)/ Chitosan Interpenetrating polymer Network Hydrogels, J. Control Release, 82,3(1987)

2.       H. Arwidson and Johanson Application of Intrinsic Viscosity and Interaction Constant as a formulation Tool for Film Coating. Int. J. Pharm., 76,91(1991).

3.       S.S.M. Abdul Aziz and W. Anderson the Influence of Casting Solvent Composition on Copolymer Films. Structure and Permeability of Acylic-Methacrylic Ester Copolymer Films. J. Pharm. Pharmacol. 28(11),801(1976).

4.       J. Spitel and R. Kinget Preparation and Evaluation of Free Films: Influence of and Solvent Composition of Method of Preparation upon the Permeability, Pharma. Act Helv. 52(3), 47(1977).

5.       R.R. Crawford and  O.K. Esmerin, Effect of Plasticizers on some physical properties of  Cellulose Acetate Phthalate Films, J. Pharm. Sci.,60,312(1971)

6.       J. Spitael and R. Kinget, Preparation and Evaluation of Free Films: Influence of Plasticizer and Filler upon the permeability Pharma. Act Helv. 52(5), 106 (1977).

7.       F. Murad In; A.G. Gliman, W.T. Rall, S.A. Nies and P. Taylor. Eds., Goodman and Gilmans  of Pharmacological Basis  Thteirapeutics,9th Edn., International, McGraw Hill Co., Inc., New York, (1996)p.762.

8.       R. Khuran, A. Ahuja and R.K. Khar, Development and Evaluation of Mucoadhesive Films of Miconazole Nitrate, Indian. J. Pharm. Sci, 62(6), 447(2000).

9.       R. Kulkani, H. Doddayya, S. Marihal, C. Patil and P. Habbu, Comparative Evaluation of Polymeric Films for Transdermal Applications. Eastern Pharmacist, 43,109(2000).

10.     K.L.K. Paranjyothy and P.P Thampi, Development of Transdermal Patches  of Verapamil Hydrochloride using sodium Carboxymethyl Guar as a Monolithic Polymeric Matrix and their in- vitro Release Studies. Indian J. Pharm. Sci, 52(2), 49(1997).

11.     Indian Pharmacopoeia, Vol, 4th Edn, The Controller of Publications, New Delhi, (1996) p.54.

12.     C.J. Salmon, S.A. Bravo and M.A. Lamas, In-vitro Studies of Diclofenac Sodium Controlled- release from Biopolymeric Hydrophilic Matrices, J. Pharm. Pharmaceut. Sci., 5(3), 213 (2002).

13.     Donald L. Wise, Hand Book of Pharmaceutical Controlled Release Technology, 1st Edn, Marcel Dekker, Cambridge Scientific Inc., Cambridge, (2005) p.187.

 

 

 

 

Received on 10.04.2014       Modified on 15.06.2014

Accepted on 15.07.2014     ©A&V Publications All right reserved

Res. J. Pharm. Dosage Form. & Tech. 7(1): Jan.-Mar. 2015; Page 69-73

DOI: 10.5958/0975-4377.2015.00010.5